Verastem Oncology
VSTM
#6928
Rank
C$1.03 B
Marketcap
C$11.41
Share price
3.90%
Change (1 day)
-4.99%
Change (1 year)

Earnings for Verastem Oncology (VSTM)

Earnings in 2026 (TTM): -C$0.29 Billion

According to Verastem Oncology 's latest financial reports the company's current earnings are C$87.52 Million. In 2025 the company made an earning of -C$0.3 Billion a decrease over its 2024 earnings that were of -C$0.19 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Verastem Oncology from 2011 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$0.29 Billion-5.86%
2025 -C$0.3 Billion60.57%
2024 -C$0.19 Billion49.31%
2023 -C$0.13 Billion18.36%
2022 -C$0.11 Billion3.67%
2021 -C$0.11 Billion5.43%
2020 -C$96.31 Million-54.74%
2019 -C$0.22 Billion105.99%
2018 -C$0.11 Billion6.83%
2017 -C$96.69 Million86.06%
2016 -C$51.97 Million-37.03%
2015 -C$82.52 Million8.43%
2014 -C$76.1 Million29.52%
2013 -C$58.76 Million28.6%
2012 -C$45.69 Million133.9%
2011 -C$19.54 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
C$9.84 B-3,521.31%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
C$2.08 B-823.64%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$11.25 B-4,007.98%๐Ÿ‡ฌ๐Ÿ‡ง UK
Curis
CRIS
-C$12.05 Million-95.82%๐Ÿ‡บ๐Ÿ‡ธ USA